These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17202460)

  • 1. p53 and tumor suppression.
    Van Dyke T
    N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer biology: can less be more for p53?
    Berns A
    Nature; 2006 Sep; 443(7108):153-4. PubMed ID: 16971934
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
    Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
    Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenes in tumors of gallbladder and biliary tract.
    Enjoji M; Nakamuta M; Nawata H
    Fukuoka Igaku Zasshi; 2004 Feb; 95(2):31-5. PubMed ID: 15101197
    [No Abstract]   [Full Text] [Related]  

  • 11. [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].
    Hainaut P
    Bull Cancer; 2000 Jan; 87(1):11-8. PubMed ID: 10673626
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 13. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
    Levine AJ
    Biol Chem Hoppe Seyler; 1993 Apr; 374(4):227-35. PubMed ID: 8329141
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal dissection of p53 function in vitro and in vivo.
    Christophorou MA; Martin-Zanca D; Soucek L; Lawlor ER; Brown-Swigart L; Verschuren EW; Evan GI
    Nat Genet; 2005 Jul; 37(7):718-26. PubMed ID: 15924142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclin-dependent kinase 4 inhibitor a and tumor].
    Gong Z; Fu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):219-21. PubMed ID: 11402455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS; Harper JW; O'Connor PM; Velculescu VE; Canman CE; Jackman J; Pietenpol JA; Burrell M; Hill DE; Wang Y
    Cancer Res; 1994 Mar; 54(5):1169-74. PubMed ID: 8118801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice.
    Landesman-Bollag E; Channavajhala PL; Cardiff RD; Seldin DC
    Oncogene; 1998 Jun; 16(23):2965-74. PubMed ID: 9662328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INK4a/ARF locus and human cancer.
    Enders GH
    Methods Mol Biol; 2003; 222():197-209. PubMed ID: 12710688
    [No Abstract]   [Full Text] [Related]  

  • 20. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.